Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.

Intramuscular recombinant alpha interferon (rIFN-2A; 9 million IU given for 5 days during a 9-day treatment period) was compared with topical acyclovir in a double-blind, placebo-controlled trial for the treatment of first-episode genital herpes simplex virus (HSV) infection and for subsequent alter...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Levin, M J, Judson, F N, Eron, L, Bryson, Y J, Corey, L, Murray, M, Scheer, R R
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1989
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172507/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2751279/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.5.649
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!